Authors
Loading...
Research demonstrates enhanced paclitaxel delivery in cancer cells using a novel nanocarrier approach, indicating improved treatment potential.
Li et al. (2026) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: